SCHEMBL28043889

SCHEMBL28043889

Cc1cc(C)cc(-c2cc(NCc3ccc4[nH]ncc4c3)nc(N)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 5/20 0.43
▸ AURKB Q96GD4 3/20 0.43
▸ AURKA O14965 2/20 0.43
▸ PDPK1 O15530 2/20 0.43
▸ CLK2 P49760 5/20 0.43
▸ DYRK1A Q13627 5/20 0.43
▸ CLK4 Q9HAZ1 5/20 0.43
▸ CLK1 P49759 4/20 0.43
▸ DYRK1B Q9Y463 4/20 0.43
▸ CLK3 P49761 2/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ ROCK1 Q13464 4/20 0.41
▸ ROCK2 O75116 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28043969 0.91 AURKA (0.43) TGFBR1AURKBAURKAPDPK1CLK2
SCHEMBL15757718 0.81 NUDT1 (0.54) TGFBR1AURKBCLK2DYRK1ACLK4
SCHEMBL28151194 0.76 NPC1 (0.49) TGFBR1AURKBAURKAPDPK1MAPK1
SCHEMBL28043938 0.74 PTGS2 (0.54) —
SCHEMBL28152251 0.74 CA1 (0.55) RAB9A
SCHEMBL15757372 0.73 NUDT1 (0.54) TGFBR1AURKBAURKAPDPK1CLK2
SCHEMBL17413739 0.73 AURKB (0.61) TGFBR1AURKBAURKAPDPK1CLK2
SCHEMBL28151149 0.73 HRH4 (0.64) TGFBR1AURKBAURKAPDPK1CYP2D6
SCHEMBL2598559 0.72 CLK4 (0.50) TGFBR1AURKBAURKACLK2DYRK1A
SCHEMBL28151182 0.72 HRH4 (0.52) ALDH1A1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 — — CN disclosed
CN-106794181-A MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions 托马斯·黑勒戴药物研究基金会 2017-05-31 — — CN disclosed
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 — — CN disclosed
Send feedback